{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/depression/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"026c474a-d688-5999-a8bd-67dd4cb231c3","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field bc177fe6-e19f-4384-a2ff-d90f332887d2 --><h2>What is the differential diagnosis?</h2><!-- end field bc177fe6-e19f-4384-a2ff-d90f332887d2 -->","summary":"","htmlStringContent":"<!-- begin item 47b21291-f6f1-4ed3-8792-4af2d3c4c184 --><!-- begin field 6e938572-5712-4ae3-992e-3380734d2114 --><p>The differential diagnosis of depression includes: </p><ul><li><strong>Grief reaction</strong> — depressive symptoms may be transiently present in normal grief. Uncomplicated bereavement and major depression share many symptoms, but active suicidal thoughts, psychotic symptoms, and inappropriate guilt are rare with normal bereavement. Table 1 compares the different characteristics of grief and depression.</li></ul><p><strong>Table 1. </strong>Depression and grief compared.</p><table data-table-id=\"0c7b62fe-12a3-4295-9038-acce014efe96\"><thead><tr><th scope=\"col\">Characteristic</th><th scope=\"col\">Grief</th><th scope=\"col\">Depression</th></tr></thead><tbody><tr><td>Mood</td><td>Sadness and dysphoria</td><td>Protracted and constant depression</td></tr><tr><td>Distress</td><td>Relates to a particular loss</td><td>Is usually pervasive and affects all facets of life</td></tr><tr><td>Guilt</td><td>Regrets and guilt over specific events</td><td>Excessive feelings of guilt</td></tr><tr><td>Hope</td><td>Episodic and focal loss of hope, but the person is able to look forward to the future</td><td>Hopelessness is persistent and pervasive </td></tr><tr><td>Pleasure</td><td>Interests and capacity for pleasure intact</td><td>Markedly diminished interest or pleasure in activities </td></tr><tr><td>Self-worth</td><td>Maintained </td><td>Worthlessness</td></tr><tr><td>Suicidal ideation</td><td>Passive and fleeting desire </td><td>Preoccupation with a desire to die</td></tr><tr><td>Symptom fluctuations</td><td>Grief comes in waves, but improves with time</td><td>Constant </td></tr><tr><td colspan=\"3\"><strong>Data from: </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/depression/references/\">Widera and Block, 2012</a>]</td></tr></tbody></table><ul><li><strong>Anxiety disorders</strong> — this frequently occurs along with depression. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>. </li><li><strong>Bipolar disorder</strong> — major depression is accompanied by, or interspersed with mania, hypomania or mixed episodes. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/bipolar-disorder/\">Bipolar disorder</a>.  </li><li><strong>Premenstrual dysphoric disorder</strong> — characterised by depressed mood, anxiety and irritability during the week before menses and resolving with menses. </li><li><strong>Neurological conditions</strong>, such as Parkinson's disease, multiple sclerosis, dementia. <ul><li><strong>Dementia may present as depression and vice versa </strong>—<strong> </strong>distinguishing depression from dementia can be difficult, as they share symptomatology (disorientation, memory loss, and distractibility). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dementia/\">Dementia</a>.</li></ul></li><li><strong>Substances and adverse drug effects.</strong><ul><li>Carbon monoxide poisoning can present with irregularities of the mental state, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/carbon-monoxide-poisoning/\">Carbon monoxide poisoning</a>.</li><li>Substance misuse (for example alcohol, anabolic steroids, cannabis, cocaine, narcotics) is frequently associated with symptoms of depression.</li><li>Drug adverse effects are an uncommon cause of depression. Examples include centrally-acting antihypertensives (such as methyldopa), lipid-soluble beta-blockers (such as propranolol), central nervous system depressants, opioid analgesics, and isotretinoin.</li></ul></li><li><strong>Hypothyroidism</strong> — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a>.</li><li><strong>Obstructive sleep apnoea syndrome</strong> — depressive symptoms are a common consequence of OSAS and can be reversed on treatment for OSAS. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/obstructive-sleep-apnoea-syndrome/\">Obstructive sleep apnoea syndrome</a>. </li></ul><!-- end field 6e938572-5712-4ae3-992e-3380734d2114 --><!-- end item 47b21291-f6f1-4ed3-8792-4af2d3c4c184 -->","topic":{"id":"5f794dff-eed8-52d6-bb65-1b1a9b1fc50a","topicId":"1b270734-f24e-4b58-8355-adaec350f356","topicName":"Depression","slug":"depression","lastRevised":"Last revised in February 2021","chapters":[{"id":"b34732f5-da05-5558-ac7e-4169aea1302d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bd7d7dbf-c3a1-5690-8d7b-8fe76ab04a16","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"cd426153-dec3-52c5-a8ab-af99800c0ec3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"69de9fdc-1e49-5a89-8dc8-72e207b8e9d1","slug":"changes","fullItemName":"Changes"},{"id":"a3c07602-3d45-5287-8c9a-8f9efd7a336a","slug":"update","fullItemName":"Update"}]},{"id":"f87fe236-c4f0-50f8-b694-28b5778f138d","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f1acf59a-ed11-5fb0-afc0-cee8532f5512","slug":"goals","fullItemName":"Goals"},{"id":"e98a7293-7a01-5fcc-9e1a-89b044ef1a02","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4182b8a5-9b8d-55e9-a4d9-fad2ca31d873","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c55afa55-15bf-5a19-94a8-21ab0c17f7b7","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a6e7d7a8-fed0-5900-aab1-c863964e870a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"72e01363-0933-5668-b378-6249cb2b64f0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d36d2b88-dd20-5f53-882c-81e310273361","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"6358ea37-2401-503d-97aa-9d7fa8d3914d","slug":"definition","fullItemName":"Definition"},{"id":"d34c93b9-e882-588a-8711-b0acdcba167b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f8f0d70d-670c-5aae-8508-7f5d3871c3ee","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6b8dc395-d0cf-5820-9d98-cec770054a06","slug":"complications","fullItemName":"Complications"},{"id":"8ed2c15a-e56e-5667-9aa5-18c0957ec394","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"68029dcd-ffd8-58da-b515-711db2fe0564","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d4c125e5-95c8-5ac3-b5fa-10c5c9889c60","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"026c474a-d688-5999-a8bd-67dd4cb231c3","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"55c3f695-d02f-5148-bc68-ddbcddf71e3f","fullItemName":"Management","slug":"management","subChapters":[{"id":"a78bc764-d878-5441-b8d6-cbbcf394ce92","slug":"new-or-initial-management","fullItemName":"Scenario: New or initial management"},{"id":"0266ece8-500b-56bf-8e36-0d23273b3560","slug":"ongoing-management","fullItemName":"Scenario: Ongoing management"}]},{"id":"7355d977-542a-5e6a-9151-82ef7115fa94","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"5dce855c-f4fe-577d-8f55-2d88cdf3a9a4","slug":"dose-titration","fullItemName":"Dose and titration"},{"id":"1df758ad-1fe3-526c-bb06-f19414843379","slug":"switching-antidepressants","fullItemName":"Switching antidepressants"},{"id":"6f10b153-e084-5a21-ae48-3acb33411b10","slug":"toxicity-in-overdose","fullItemName":"Toxicity in overdose"},{"id":"0a0e189c-03e7-5c82-ba71-c96545755eeb","slug":"monitoring-antidepressants","fullItemName":"Monitoring antidepressants"},{"id":"f5deab35-56d4-5f9d-bc07-f29103e961ad","slug":"pregnancy-breastfeeding","fullItemName":"Pregnancy and breastfeeding"},{"id":"f481ead9-8b60-571b-895e-d927223d993e","slug":"ssris","fullItemName":"SSRIs"},{"id":"83772b94-1512-51dd-99ad-a3fb7725267f","slug":"snris","fullItemName":"SNRIs"},{"id":"299a2937-fa9a-5b97-970b-a79af9a2fc00","slug":"tricyclic-antidepressants","fullItemName":"Tricyclic antidepressants"},{"id":"d4e99efd-b8fb-5453-9c75-f6382c8e25c5","slug":"mirtazapine","fullItemName":"Mirtazapine"},{"id":"3b9d10f7-2760-5bd9-bdf7-92f33416e2c9","slug":"moclobemide","fullItemName":"Moclobemide"},{"id":"823fe65c-0107-5657-8e8f-6ce91ed5cfb6","slug":"reboxetine","fullItemName":"Reboxetine"}]},{"id":"725ab0c0-f1a9-5756-833a-ea5c4f8721bf","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"17b06435-7e75-56bf-80c0-57858b6db92c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7eeea9f4-7f32-515a-b661-5f51a513cba7","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3907465f-bd0e-530a-b486-c2655ccaba7c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6cef4cda-5622-50b2-9759-9e03266800d3","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"59840e87-e4f4-5c49-a6f1-f67d210f3dc0","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7d357e2c-3884-5b0c-b9a3-bbf7420da7a9","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3a86a38c-4d81-57f0-ac72-7b5260328853","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"68029dcd-ffd8-58da-b515-711db2fe0564","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"e7af06f5-0d21-5e40-b397-87756bc14346","slug":"basis-for-recommendation-605","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 31ae5f18-d367-4f74-b7b7-a70700f44db6 --><h3>Basis for recommendation</h3><!-- end field 31ae5f18-d367-4f74-b7b7-a70700f44db6 -->","summary":null,"htmlStringContent":"<!-- begin item 605ac5cb-82e7-4372-a830-a70700f44c53 --><!-- begin field 61282317-427f-49c9-8bb9-a70700f44db6 --><p>This information is based on the British Medical Journal (BMJ) best practice guide <em>Depression in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/depression/references/\">BMJ, 2019</a>], the Royal Australian and New Zealand College of Psychiatrists (RANZCP) <em>Clinical practice guidelines for mood disorders </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/depression/references/\">Malhi, 2015</a>], and expert opinion in narrative reviews <em>Depression in primary care: part 1– screening and diagnosis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/depression/references/\">Ferenchick, 2019</a>], and <em>Managing grief and depression at the end of life</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/depression/references/\">Widera and Block, 2012</a>].</p><!-- end field 61282317-427f-49c9-8bb9-a70700f44db6 --><!-- end item 605ac5cb-82e7-4372-a830-a70700f44c53 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}